Cargando…

Potential of Peroxisome Proliferator-Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types

PPARγ is a therapeutic target that has been exploited for treatment of type II diabetes mellitus (T2DM) with agonist drugs. Since PPARγ is expressed by many hematopoietic, mesodermal and epithelial cancers, agonist drugs were tested and shown to have both preclinical and clinical anticancer activiti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burton, Jack D., Goldenberg, David M., Blumenthal, Rosalyn D.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2008
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528255/ https://www.ncbi.nlm.nih.gov/pubmed/18779871 http://dx.doi.org/10.1155/2008/494161

Ejemplares similares

Exploring compounds to be used as cosmetic agents that activate peroxisome proliferator‐activated receptor alpha
por: Tachibana, Keisuke, et al.
Publicado: (2022)

Polyyne Hybrid Compounds from Notopterygium incisum with Peroxisome Proliferator-Activated Receptor Gamma Agonistic Effects
por: Liu, Xin, et al.
Publicado: (2014)

Computational identification of potential chemoprophylactic agents according to dynamic behavior of peroxisome proliferator-activated receptor gamma
por: Yang, Zhiwei, et al.
Publicado: (2020)

Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma
por: Park, Hyung Kyu, et al.
Publicado: (2015)

The role of peroxisome proliferator-activated receptor gamma in prostate cancer
por: Elix, Catherine, et al.
Publicado: (2018)

Effects of Germinated Brown Rice and Its Bioactive Compounds on the Expression of the Peroxisome Proliferator-Activated Receptor Gamma Gene
por: Imam, Mustapha Umar, et al.
Publicado: (2013)

Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?
por: Green, David E., et al.
Publicado: (2011)

Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios
por: Katoch, Swati, et al.
Publicado: (2022)

Peroxisome Proliferator-Activated Receptor Gamma Polymorphisms and Coronary Heart Disease
por: Dallongeville, Jean, et al.
Publicado: (2009)

Peroxisome proliferator-activated receptor gamma signaling in human sperm physiology
por: Liu, Li-Li, et al.
Publicado: (2015)

Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma
por: Hsu, Hui-Tzu, et al.
Publicado: (2014)

Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2()
por: Lee, Yoon Kwang, et al.
Publicado: (2018)

Structural Biology Inspired Development of a Series of Human Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Ligands: From Agonist to Antagonist
por: Miyachi, Hiroyuki
Publicado: (2023)

Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation
por: Omeragic, Amila, et al.
Publicado: (2017)

Initiation of the expression of peroxisome proliferator - activated receptor gamma (PPAR gamma) in the rat ovary and the role of FSH
por: Long, Mary J, et al.
Publicado: (2009)

The Natural Compound Dansameum Reduces foam Cell Formation by Downregulating CD36 and Peroxisome Proliferator-activated Receptor-gamma; Expression
por: Park, Kang-Seo, et al.
Publicado: (2017)

Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma
por: Zhang, G Y, et al.
Publicado: (2005)

Peroxisome Proliferator-Activated Receptor-Gamma Expression in the Lung Tissue of Obese Rats
por: Hwang, Su Jin, et al.
Publicado: (2011)

Oleamide activates peroxisome proliferator-activated receptor gamma (PPARγ) in vitro
por: Alexander, Stephen PH, et al.
Publicado: (2012)

Kinetic characterization of selective peroxisome-proliferator-activated receptor gamma modulators in vitro
por: Knape, T, et al.
Publicado: (2012)

Functions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic Disorders
por: Ren, Ping, et al.
Publicado: (2015)

Clinical relevance of peroxisome proliferator-activated receptor-gamma expression in myxoid liposarcoma
por: Takeuchi, Akihiko, et al.
Publicado: (2016)

Peroxisome Proliferator-Activated Receptor Gamma in Obesity and Colorectal Cancer: the Role of Epigenetics
por: Motawi, T. K., et al.
Publicado: (2017)

Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma
por: Weidner, Philip, et al.
Publicado: (2020)

The role of peroxisome proliferator-activated receptor gamma and adiponectin in children with Kawasaki disease
por: Zhang, Ji-Yong, et al.
Publicado: (2021)

Binding of Per- and Polyfluoro-alkyl Substances to Peroxisome Proliferator-Activated Receptor Gamma
por: Almeida, Nuno M. S., et al.
Publicado: (2021)

Peroxisome proliferator‐activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target
por: Pleniceanu, Oren, et al.
Publicado: (2017)

Current Progress on Peroxisome Proliferator-activated Receptor Gamma Agonist as an Emerging Therapeutic Approach for the Treatment of Alzheimer's Disease: An Update
por: Khan, Mahmood Ahmad, et al.
Publicado: (2019)

Interaction between Calpain 5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity
por: Sáez, María E, et al.
Publicado: (2008)

Marine Natural and Nature-Inspired Compounds Targeting Peroxisome Proliferator Activated Receptors (PPARs)
por: D’Aniello, Enrico, et al.
Publicado: (2023)

Time-Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)
por: O'Sullivan, Saoirse E., et al.
Publicado: (2009)

Role of Peroxisome Proliferator-Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies
por: Garcia-Bates, Tatiana M., et al.
Publicado: (2008)

Peroxisome Proliferator-Activated Receptor Gamma and Regulations by the Ubiquitin-Proteasome System in Pancreatic Cancer
por: Stravodimou, Athina, et al.
Publicado: (2012)

Activation of peroxisome proliferator-activated receptor gamma is crucial for antitumoral effects of 6-iodolactone
por: Nava-Villalba, Mario, et al.
Publicado: (2015)

The Protective Effects of Peroxisome Proliferator-Activated Receptor Gamma in Cerebral Ischemia-Reperfusion Injury
por: Ding, Yanping, et al.
Publicado: (2020)

Peroxisome proliferator-activated receptor gamma upregulation and dietary fat levels in laying hens
por: Barzegar, Shahram, et al.
Publicado: (2021)

Hypothermia Protects against Ischemic Stroke through Peroxisome-Proliferator-Activated-Receptor Gamma
por: Shao, Shuai, et al.
Publicado: (2022)

Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases
por: Sharma, Vinesh, et al.
Publicado: (2022)

Peroxisome Proliferator Activated Receptor Gamma Sensitizes Non-small Cell Lung Carcinoma to Gamma Irradiation Induced Apoptosis
por: Kaur, Simran, et al.
Publicado: (2019)

Pioglitazone modulates the proliferation and apoptosis of vascular smooth muscle cells via peroxisome proliferators-activated receptor-gamma
por: Wan, Jing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v58mkiuvj23e1kt3l7bu0a76oh